As of November 14, 2026, Opko Health, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 19, 2026, naming 1 appointment. The latest filing names Subbarao V. Uppaluri, appointed (Form 8-K, March 19, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Opko Health, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Opko Health, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-19. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Opko Health, Inc. files it.
Also on the record for Opko Health, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 1, 2026 | Stake report, Schedule 13D/A, by FROST PHILLIP MD ET AL | 34.1% of the class | 5%+ stakes | Source |
| October 1, 2025 | Stake report, Schedule 13D/A, by FROST PHILLIP MD ET AL | 32.8% of the class | 5%+ stakes | Source |
| July 9, 2025 | Stake report, Schedule 13G/A, by Rubric Capital Management LP | 6.03% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Opko Health, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Opko Health, Inc. and the records around it.
Opko Health, Inc. elsewhere on the record
Companies that share a holder
- FROST PHILLIP MD ET AL also filed stake reports on 3 other companies: Safe Pro Group Inc. (Sep 2026), Cocrystal Pharma, Inc. (Aug 2026), Fluent, Inc. (Jan 2026)
- Rubric Capital Management LP also filed stake reports on 32 other companies: ARDELYX, INC. (Aug 2026), Enovis Corporation (Aug 2026), MeiraGTx Holdings plc (Aug 2026)
Watch Opko Health, Inc.
Get an email when Opko Health, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Opko Health, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Opko Health, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Opko Health, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-19 | In | 8-K, 2026-03-19 |
New leaders reset buying decisions — get the Full Report on Opko Health, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Opko Health, Inc., with the record behind each one.
Find candidates like senior executive at Opko Health, Inc.Every change, in the filing's words
Appointed: Subbarao V. Uppaluri
Dr. Uppaluri was appointed to the Board of Directors due to a vacancy as a result of the passing of Dr. Richard Krasno who served on the Company's Board of Directors beginning in February 2017.
- On March 18, 2026, the Board of Directors of OPKO Health, Inc. (the "Company"), appointed Subbarao V. Uppaluri, Ph.D. as a new director with immediate effect to serve until the Company's 2026 Annual Meeting of Stockholders and until his successor shall be duly elected or appointed or his earlier death or resignation.
- Dr. Uppaluri is expected to be appointed to the Compensation Committee of the Board.
- The Board has determined that Dr. Uppaluri is independent under the applicable rules of the Securities and Exchange Commission and the Nasdaq Stock Market.
- Dr. Uppaluri served as Senior Vice President and Chief Financial Officer of the Company from May 2007 until his retirement in July 2012 and as a consultant of the Company until February 2014.
- He served as the Vice President, Strategic Planning and Treasurer of IVAX from 1997 until December 2006.
- Dr. Uppaluri served in various positions, including Senior Vice President, Senior Financial Officer, Chief Investment Officer, and Controller with several publicly traded banks and began his career in engineering, marketing and research positions with multinational companies and research institutes in India and the United States.
- Dr. Uppaluri currently serves on the board of Baptist Health Homestead Hospital.
Tools for this story
Each opens in a new tab, filled in for Opko Health, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
